Natural killer cells: Biology, regulation and clinical importance;Les cellules NK: Biologie, modes de regulation et interet clinique

Hematologie

Volumn 4, Issue 1, 1998, Pages 41-49

  Granel, Brigitte ^a   Vivier, Éric ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Anti tumoral immunity; Cytokines; Cytotoxicity; Graft; ITIMs; NK lymphocytes; Phosphatases

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE; CYTOKINE; HEMOPOIETIC GROWTH FACTOR; LYMPHOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; B LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; IMMUNOGLOBULIN PRODUCTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; REVIEW; T LYMPHOCYTE;

EID: 0031929303     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kiessling R, Klein E, Wigzell H. « Natural » killer cells in the mouse. Cytotoxic cells with specificity for mouse Moloney leukemia cells: specifity and distribution according to genotype. Eur J Immunol 1975 ; 5 : 112-7.
2. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990 ; 12 : 2421-38.
3. Vivier E, Sorrel JM, Ackerly M, Robertson MJ, Rasmussen RA, Levine H, Anderson P. Developmental regulation of a mucinlike glycoprotein selectively expresssed on natural killer cells. J Exp Med 1993 ; 178 : 2023-33.
4. Lanier LL, Corliss B, Philips JH. Arousal and inhibition of human NK cells, Immunol Rev 1997 ; 155 : 145-54.
5. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without killer cells. N Engl J Med 1989 ; 320 : 1731-5.
6. Vely F, Vivier E. Mécanismes moléculaires de la cytotoxicité des cellules NK. médecine/ science 1996 ; 12 : 458-64.
7. Vivier E, Rochet N, Kochan JP, Presky DH, Schlossman SF, Anderson P. Structural similarities between Fc receptors and T cell receptors expression of the γ subunit of FœRI in human T cells, NK cells and thymocytes. J Immunol 1991 ; 147 : 4263-70.
8. Leibson PJ. Signal transduction during natural killer cell activation : inside the mind of a killer. Immunity 1997 ; 6 : 655-61.
9. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P. Tyrosine phosphorylation of the FcyRIII(CD16) : ζ complex in human natural killer cells. J Immunol 1991 ; 146 : 206-10.
10. Tanäkä M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motȯyoshi K, Mizuki M, Tagawa S, Öhga S, Hatake K, Drummond AH, Nagata S. Fas ligand in human serum. Nature Medicine 1996 ; 2 : 317-22.
11. Störkus WJ, Alexander J, Payne A, Dawson JR, Cresswéll P. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Nat! Acad Sci USA 1989 ; 86 : 2361-4.
12. Lanier LL Natural killer cells : from no receptor to too many. Immunity 1997 ; 6 : 371-8.
13. Mandelboim O, Reyburn HT, Sheu EG, Valés-Gomez M, Davis DM, Pazmany L, Strominger JL. The binding site of NK receptors on HLA-C molecules. Immunity 1997 ; 6 : 341-50.
14. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996 ; 157 : 4741-5.
15. Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol 1997 ; 27 : 1374-80.
16. Ljunggren HG, Kärre K. In search of the « missing self » : MHC molecules and NK cell recognition, Immunol Today 1990 ; 11 : 237-44.
17. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997 ; 7 : 273-82.
18. Cambiaggi A, Verthuy C, Naquet P, Romagné F, Ferrier P, Biassoni R, Moretta A, Vivier E. Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD 158b). Proc Natl Acad Sci USA 1997 ; 94 : 8088-92.
19. + T lymphocytes subsets that express HLA class-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations, Proc Natl Acad Sci USA 1996 ; 93 : 12433-8.
20. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK and T cells, Immunol Today 1996 ; 17 : 86-91.
21. Le Dréan E, Vély F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 1998 ; sous presse.
22. Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern PL. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 1997 ; 18 : 89-95.
23. Ikeda H, Lethé B, Lehmann F, Van Baren N, Baurain JF, De Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory Receptor. Immunity 1997 ; 6 : 199-208.
24. + T cells expressing NK receptors for major histocompatibility complex class I after « three-loci » HLA-incompatible bone marrow transplantation. Blood 1996 ; 87 : 3993-4000.
25. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 1997 ; 158 : 5083-6.
26. Murphy WJ, Longo DL. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation, Immunol Rev 1997 ; 157 : 1667-76.
27. +dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 1996 ; 88 : 2279-87.
28. Cervantes F, Pierson BA, McGlave PB, Verfaillie CM, Miller JS. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture. Blood 1996 ; 87 : 2476-85.
29. Salazar-Mather TP, Ishikawa R, Biron C. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol 1996 ; 157 : 3055-6.
30. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997 ; 99 : 937-43.